Cleared Special

K220492 - COPAL exchange G hip spacer (FDA 510(k) Clearance)

Mar 2022
Decision
29d
Days
Class 2
Risk

K220492 is an FDA 510(k) clearance for the COPAL exchange G hip spacer. This device is classified as a Prosthesis, Hip, Hemi-, Femoral, Metal/polymer, Cemented Or Uncemented (Class II - Special Controls, product code KWY).

Submitted by Heraeus Medical GmbH (Wehrheim, DE). The FDA issued a Cleared decision on March 23, 2022, 29 days after receiving the submission on February 22, 2022.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3390.

Submission Details

510(k) Number K220492 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 22, 2022
Decision Date March 23, 2022
Days to Decision 29 days
Submission Type Special
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code KWY - Prosthesis, Hip, Hemi-, Femoral, Metal/polymer, Cemented Or Uncemented
Device Class Class II - Special Controls
CFR Regulation 21 CFR 888.3390